title: The role of body mass in the response to growth hormone therapy.
abstract: Obesity is associated with normal or increased growth despite diminished GH secretion compared to lean children. The mechanism by which adequate growth is maintained in the presence of low GH levels is unknown, but is possibly mediated at the GH receptor level. To probe this hypothesis, we examined the relationship between GH responsivity, body mass index (BMI) and plasma GH-binding protein (GH-BP)/receptor level in 43 GH-deficient children during treatment with a fixed dose of GH (0.18 mg/kg.week). Before treatment, BMI [expressed as standard deviation score (SDS) for age (BMI-SDS)] did not correlate with either growth velocity or serum insulin-like growth factor-I (IGF-I). In contrast, after 12 months of GH therapy BMI-SDS correlated directly with plasma IGF-I (P < 10(-5)) and growth velocity (P < 10(-3)). These findings parallel those obtained for GH-BP vs. the response to GH, suggesting that BMI and GH-BP are covariants. The interrelationships among BMI, GH-BP, and response to GH were further probed by multiple regression analysis. Partial correlation coefficients vs. response to GH were consistently stronger for GH-BP than for BMI-SDS, indicating that GH-BP is the dominant factor between these two covariants in determining responsiveness to GH. The data suggest a primary role for GH-BP/receptor levels in determining GH action, with secondary but significant effects of nutrition and degree of adiposity. The latter may be mediated through the impact of nutrition and body mass on GH-BP/receptor levels.
authors: Department of Pediatrics, Baystate Medical Center, Springfield, Massachusetts 01199.
authors: P M
authors: PM
authors: Martha
authors: E O
authors: EO
authors: Reiter
authors: N
authors: N
authors: Dávila
authors: M A
authors: MA
authors: Shaw
authors: J H
authors: JH
authors: Holcombe
authors: G
authors: G
authors: Baumann
mesh_terms: D001827:Body Height; D015992:Body Mass Index; D002352:Carrier Proteins / Q000097:blood; D002648:Child; D004305:Dose-Response Relationship, Drug; D005260:Female; D013006:Growth Hormone / Q000172:deficiency / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D008297:Male
chemical_list: D002352:Carrier Proteins; D013006:Growth Hormone; C051815:somatotropin-binding protein